Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 7 of 7 publications.

Kupperman BD, Keyloun KR, Campbell JH, Zhou X, Davenport E, Bakri SJ. Decreased vision improvement in DME eyes with longer duration larger amounts of excess edema: a post-hoc analysis of protocol T. Presented at the 2021 54th Retina Society Annual Scientific Meeting; September 29, 2021. Chicago, IL.

Ho M, Gonzalez JM, Mansfield C, Wilson L. Three preference studies sponsored by FDA CBER to inform benefit-risk assessment for biologics. Presented at the Virtual ISPOR 2021 Conference; May 20, 2021.

Gonzalez Sepulveda JM, Irony T, Mansfield C, Wilson L. Stated preferences to inform benefit-risk assessment for biologics-three FDA-sponsored studies. Presented at the 2020 ISPOR Virtual Conference; May 18, 2020.

Herring WL, Grant TJ, Mladsi DM. A mathematical model to estimate the health benefits and costs of diabetic retinopathy screening programs. Presented at the 2015 Institute for Operations Research and Management Science Computing Conference; January 12, 2015. Richmond, VA.

Stull DE, Schaefer M, Crespi S, Sandor DW. Relationship of nasal congestion and ocular symptoms with patient-reported sleep, mood, and productivity. Presented at the annual meeting of the American College of Allergy, Asthma, & Immunology; November 2008. Seattle, WA.

Arana A, Arellano FM, Rivero E, Parvesi M, Dey D, Wentworth CE. Intravitreal (IVT) injectionrelated ocular adverse events in the general population of the United States of America. Presented at the 24th International Conference on Pharmacoepidemiology; 2008.

Astier P, Arana A, Oterino D, Lopez MA, Piero S. Cost analysis for the different strategies in cataract surgery. Presented at the V Congreso de la Sociedad Española de Salud Pública y Administración Sanitaria; 1993. Granada, Spain.